4Schondorf T,Kurbarcher CM,Gohring UJ,et al.Induction of MDR1-gene expression by antineoplastic agents in ovarian cancer lines.Anticancer Res,2002,22(4):2199 ～ 2203.
7Kamazawa S,Kigawa J,Kanamori Y,et al.Multidrug.resistance gene-1 is a useful predictor of paclitaxel-based chemotherapy for patients with ovarian cancer.Gynecol Oncol,2002,86(2):171 ～ 176.
8Kolfschoten GM,Hulscher TM,Pinedo HM,et al.Drug resistance features and S-phase fraction as possible determinants for drug response in a panel of human ovarian cancer xenografts.Br J Cancer,2000,83(7):921 ～ 927.
9Kavallaris M,Leary JA,Barrett JA,et al.MDR1 and MRP gene expression in epithelial ovarian tumors.Cancer Letter,1996,102(1-2):7 ～ 16.
8Yin M B,Guo B,Voigt W,et al. Novel cellular determination for reversal of multidrug resistance in cells expressing of p170-glycoprotein[J].Biochem Biophys Acta, 1998,1401(3):265-276.
9Jenks S. RAC approves gene protocol for adult twins with AIDS[J].J Natl Cancer Inst,1992,84(19):1468-1469.
10Khalifa M A,Abdoh A A,Mannel R S,et al. P-glycoprotein as a prognostic indictor in prechemothereapy and postchemotherapy ovarian adenocarcinoma[J]. Int J Gynecol Pathol ,1997,16(1):69-75.
